查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018556

牙科骨移植材料和骨替代材料市場：按產品類型、材料、應用和最終用戶分類－2026-2032年全球市場預測

Dental Bone Grafts & Substitutes Market by Product Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年牙科骨移植和骨替代材料市場價值 13 億美元，預計到 2026 年將成長至 13.9 億美元，複合年成長率為 7.68%，到 2032 年將達到 21.9 億美元。

主要市場統計數據
基準年 2025 13億美元
預計年份：2026年 13.9億美元
預測年份 2032 21.9億美元
複合年成長率 (%) 7.68%

牙科骨移植材料及替代品的策略性引入：聚焦臨床因素、材料發展、法規環境和買方期望

牙科骨移植材料及其替代品領域融合了生物材料科學、外科技術進步和以患者為中心的護理模式。臨床醫生基於對移植骨生物學、操作特性和長期整合的深入理解，選擇能夠最佳化再生效果並最大限度減少併發症的產品。同時，材料科學家和醫療設備開發人員不斷改進複合材料配方、表面化學和支架結構，以增強其骨誘導性和可吸收性。這些平行發展趨勢影響著醫院口腔科和口腔外科的採購討論和臨床訓練需求。

生物創新、手術流程、報銷趨勢和跨學科合作正在推動變革性變化，重塑牙科骨移植領域。

近年來，生物製劑、製造技術的進步以及臨床工作流程的整合，推動了牙科骨移植材料及其替代方案領域的變革性轉變。支架設計和生物活性表面功能化的創新拓展了治療選擇，實現了更可預測的骨再生和更短的治療週期。同時，微創手術技術和數位化規劃工具的普及降低了治療方案的差異性，也催生了對能夠無縫融入精簡工作流程和既定治療路徑的產品的需求。

評估 2025 年美國關稅對供應鏈、價格壓力、臨床可用性和籌資策略的累積影響。

2025年美國關稅的實施和貿易政策的調整將對牙科植入物生態系統產生多方面的影響，遠不止表面上的價格波動。關稅措施可能會擾亂陶瓷、聚合物和加工後的同種異體組織成分等原料的現有供應鏈，迫使製造商重新評估其籌資策略和庫存政策。為此，供應鏈負責人正著力於近岸外包、多元化採購和延長交貨週期，以降低關稅波動帶來的風險，並確保對臨床客戶的持續供應。

關鍵細分洞察揭示了產品類型、材料科學、臨床應用和最終用戶環境如何決定部署路徑和創新重點。

詳細的市場區隔分析揭示了產品屬性、材料成分、臨床應用和醫療環境如何影響產品的採用模式和創新重點。根據產品類型，市場可細分為同種異體移植、自體移植、複合移植、合成移植和異質骨移植。其中，同種異體移植進一步細分為脫礦凍乾骨同種異體移植（DFDBA）和凍乾骨同種異體移植（FDBA）。複合移植進一步分為陶瓷複合材料和有機複合材料，合成移植分為生物活性玻璃、陶瓷和聚合物，異質骨移植分為牛和豬源材料。這種產品分類突顯了不同的價值提案：用於骨誘導的生物活性基質、複合材料。

影響美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和成長要素，以及這些趨勢和動力如何影響市場准入、監管和臨床應用。

區域趨勢對法律規範、臨床實務模式和供應鏈設計有著深遠的影響，進而塑造了各區域產品的開發和商業化方式。在美洲，監管政策的明確化和對臨床結果數據的日益重視推動了對循證植入物和通路的需求。同時，採購方融入醫療保健系統也提升了價值提案和合約柔軟性的重要性。在歐洲、中東和非洲，監管環境的多樣性和支付方的差異性凸顯了區域性監管策略和有針對性的臨床教育計畫的重要性，要求製造商核准中央和區域核准以及各國的報銷政策。在亞太地區，強大的製造業基礎和不斷擴展的專業教育舉措正在推動新材料的快速應用，但各地監管的細微差別和臨床方案的差異使得市場准入需要採取個人化的策略。

競爭情報整合了主要參與者的產品系列、研發重點、夥伴關係模式和商業化策略。

牙科骨移植材料及替代品領域的競爭格局主要體現在產品系列的廣度、臨床證據的深度、合作能力以及供應鏈的可靠性等。主要企業正透過投資產品模組化來提升自身競爭力，這使得臨床醫生能夠根據特定手術需求選擇合適的移植材料，同時簡化庫存管理。此外，那些將材料創新與完善的臨床註冊研究和外科醫生主導的臨床試驗相結合的企業，展現出降低產品應用門檻、將技術優勢轉化為臨床醫生偏好的能力。與學術機構的合作以及跨國分銷合作，透過加速證據產生和拓展新市場，進一步鞏固了企業的市場地位。

為行業領導者提供最佳化研發、供應鏈彈性、報銷參與和臨床醫生招聘策略的實用建議。

行業領導者應優先考慮科學嚴謹性、業務永續營運和商業性導向的務實結合，以加速永續推廣。首先，應投資以產生針對特定手術終點和長期綜合結果的臨床證據，使臨床醫生和支付者能夠對不同方案進行知情比較。其次，應實現供應鏈多元化，探索區域製造和策略夥伴關係關係，以減輕關稅波動的影響，並縮短關鍵零件的補貨前置作業時間。第三，應使產品開發與臨床醫生的工作流程相契合，優先考慮操作特性、包裝便利性和與數位化手術規劃平台的兼容性，以減少術中操作的阻力。

本文檔詳細介紹了為確保獲得可靠的見解而採用的調查方法，包括資料來源、相關人員訪談、檢驗技術和分析框架。

本研究整合了定性和定量方法，以確保基於關鍵相關人員的意見和檢驗的二手證據得出穩健且可重複的研究結果。主要資料來源包括對執業口腔外科醫師、採購經理和臨床研究人員的訪談，並輔以對監管文件、產品標籤和同行評審臨床文獻的審查。二手檢驗包括與公開的監管文件和程序規範指南進行交叉核對，以確保解釋符合當前的臨床實踐和合規要求。這些資訊經過三角驗證，以最大限度地減少偏差，並提高關於臨床效用、產品特性和操作注意事項的結論的可靠性。

結論總結了對整個價值鏈上的相關人員在臨床趨勢、技術融合和營運重點方面的策略見解。

牙科骨移植和骨替代材料領域的不斷發展，為價值鏈上的所有相關人員帶來了機會和挑戰，也要求他們制定清晰的策略。材料和手術技術的進步有望改善患者預後並提高手術效率，但其應用取決於可靠的證據、穩定的供應以及與醫療保險報銷系統的契合度。供應鏈多元化和以臨床醫生為中心的產品設計等營運挑戰決定了哪些創新技術能夠最終應用於常規臨床實踐，而區域法規和物流因素則要求制定針對特定打入市場策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 牙科骨移植材料和骨骼替代材料市場：按產品類型分類

  • 同種異體移植
    • 脫鈣凍乾同種異體骨（DFDBA）
    • 凍乾骨同種異體移植材料（FDBA）
  • 自體骨移植
  • 複合移植材料
    • 陶瓷複合材料
    • 有機複合材料
  • 合成接枝材料
    • 生物活性玻璃
    • 陶瓷
    • 聚合物
  • 異種移植材料
    • 牛
    • 豬

第9章 牙科骨移植材料與骨替代材料市場：依材料分類

  • 生物活性玻璃
  • 硫酸鈣
  • 複合材料
  • 羥磷石灰
  • 磷酸三鈣

第10章：牙科骨移植材料和骨替代材料市場：按應用領域分類

  • 植入植入部位的準備
  • 齒槽骨增容手術
  • 鼻竇增高術
  • 套接字存儲

第11章 牙科骨移植材料和骨替代品市場：按最終用戶分類

  • 門診手術中心
  • 牙醫診所
  • 醫院

第12章 牙科骨移植材料和骨替代材料市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 牙科骨移植材料和骨骼替代材料市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 牙科骨移植材料和骨替代物市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國牙科骨移植與骨替代材料市場

第16章：中國牙科骨移植與骨骼替代材料市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BioHorizons, Inc.
  • botiss biomaterials GmbH
  • Collagen Matrix, Inc.
  • curasan AG
  • Dentium Co., Ltd.
  • Dentsply Sirona Inc.
  • Envista Holdings Corporation
  • Geistlich Pharma AG
  • Institut Straumann AG
  • Johnson & Johnson
  • Kuros Biosciences AG
  • LifeNet Health, Inc.
  • Medtronic plc
  • NovaBone Products LLC
  • OsteoBiol
  • Osteogenics Biomedical, Inc.
  • Purgo Biologics Co., Ltd.
  • RTI Surgical, Inc.
  • Stryker Corporation
  • ZimVie Inc.
Product Code: MRR-A339DAEFB1BD

The Dental Bone Grafts & Substitutes Market was valued at USD 1.30 billion in 2025 and is projected to grow to USD 1.39 billion in 2026, with a CAGR of 7.68%, reaching USD 2.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.30 billion
Estimated Year [2026] USD 1.39 billion
Forecast Year [2032] USD 2.19 billion
CAGR (%) 7.68%

A strategic introduction to dental bone grafts and substitutes highlighting clinical drivers, material evolution, regulatory context, and buyer expectations

The dental bone grafts and substitutes domain sits at the intersection of biomaterials science, surgical technique evolution, and patient-centric care models. Clinicians rely on a nuanced understanding of graft biology, handling characteristics, and long-term integration to select products that optimize regenerative outcomes while minimizing complications. Meanwhile, material scientists and device developers continue to refine composite formulations, surface chemistry, and scaffold architecture to enhance osteoconductivity and resorption profiles. These parallel developments shape procurement conversations and clinical training needs across dental specialty practices and hospital-based oral surgery units.

Transitioning from foundational science to clinical application requires alignment among regulatory bodies, payers, and professional societies. Regulatory clarity on processed human tissue, xenogeneic materials, and synthetic constructs influences product development timelines and labeling. At the same time, reimbursement pathways and procedure coding affect clinical adoption velocity and the relative economics of different grafting strategies. As a result, stakeholders are increasingly focused on evidence generation, including comparative effectiveness research and real-world outcomes, to substantiate claims and inform guideline development. This introductory overview frames subsequent sections that examine disruptive trends, policy impacts, segmentation dynamics, regional variability, competitive behavior, and pragmatic recommendations for market participants.

Transformative shifts reshaping dental bone graft landscape driven by biologics innovation, surgical workflows, reimbursement trends, and cross-disciplinary collaboration

Recent years have witnessed transformative shifts that are redefining the landscape for dental bone grafts and substitutes, driven by advances in biologics, manufacturing, and clinical workflow integration. Innovations in scaffold design and bioactive surface functionalization have expanded the therapeutic toolkit, enabling more predictable bone regeneration and shorter treatment timelines. Concurrently, minimally invasive surgical techniques and digital planning tools have reduced procedure variability, creating opportunities for products that integrate seamlessly into streamlined workflows and delivered care pathways.

Moreover, cross-disciplinary collaboration between materials scientists, oral surgeons, and clinical researchers has accelerated translational pipelines. As translational evidence accumulates, procurement stakeholders and clinicians are more willing to adopt next-generation grafts that demonstrate clear handling and healing advantages. At the same time, heightened expectations for safety, traceability, and post-market surveillance have raised the bar for manufacturers, prompting investments in quality systems and clinical data collection. Taken together, these shifts favor innovators who can couple robust clinical evidence with supply reliability and user-centered product design, while pragmatic adoption will depend on reimbursement alignment and clinician training initiatives.

Assessment of the cumulative impact of United States tariffs in 2025 on supply chains, pricing pressures, clinical availability, and procurement strategies

The imposition of tariffs and trade policy adjustments in the United States in 2025 presents a multifaceted influence on the dental grafts ecosystem that extends beyond headline pricing effects. Tariff measures can disrupt established supply chain flows for raw materials such as ceramics, polymers, and processed allogeneic tissue components, prompting manufacturers to reassess sourcing strategies and inventory policies. In response, supply planners have emphasized near-shoring, multi-sourcing, and longer procurement horizons to mitigate exposure to tariff volatility and maintain continuity for clinical customers.

Consequently, procurement departments within dental clinics, ambulatory surgical centers, and hospitals are evaluating contract terms and inventory buffers to preserve procedural schedules and clinician confidence. In parallel, manufacturers are recalibrating cost structures by optimizing manufacturing footprints, renegotiating supplier agreements, and streamlining production footprints to preserve product accessibility. Importantly, clinicians and purchasing leaders are paying closer attention to total cost of care considerations, balancing product unit pricing against handling benefits, integration times, and outcomes that influence follow-up procedures. In sum, the tariff environment has emphasized the imperative for resilient supply chains, transparent supplier communication, and scenario planning to ensure uninterrupted patient care.

Key segmentation insights revealing how product types, material science, clinical applications, and end-user settings determine adoption pathways and innovation focus

A detailed segmentation view uncovers how product attributes, material composition, clinical application, and care setting shape adoption patterns and innovation priorities. Based on Product Type, the market is studied across Allografts, Autografts, Composite Grafts, Synthetic Grafts, and Xenografts, with Allografts further studied across Demineralized Freeze Dried Bone Allograft (DFDBA) and Freeze Dried Bone Allograft (FDBA), Composite Grafts further studied across Ceramic Composites and Organic Composites, Synthetic Grafts further studied across Bioactive Glass, Ceramics, and Polymers, and Xenografts further studied across Bovine and Porcine. This product taxonomy highlights distinct value propositions: biologically active matrices for osteoinduction, synthetics for handling consistency, and composites for tailored resorption kinetics.

Based on Material, the market is studied across Bioactive Glass, Calcium Sulfate, Composite Materials, Hydroxyapatite, and Tricalcium Phosphate, which underscores how raw material selection informs mechanical behavior, resorption timeline, and integration biology. Based on Application, the market is studied across Implant Site Preparation, Ridge Augmentation, Sinus Lift, and Socket Preservation, revealing procedure-specific requirements for graft volume, stability, and predictability. Based on End User, the market is studied across Ambulatory Surgical Centers, Dental Clinics, and Hospitals, each presenting unique procurement frameworks, clinician skill mixes, and procedural throughput that influence product specification and value communication. Integrating these segmentation axes clarifies where technical innovation, clinical evidence, and commercial strategy will most effectively intersect to drive adoption.

Regional dynamics and growth enablers across Americas, Europe Middle East & Africa, and Asia-Pacific that influence access, regulation, and clinical practice adoption

Regional dynamics exert a powerful influence on regulatory frameworks, clinician practice patterns, and supply chain design, shaping how products are developed and commercialized in different geographies. In the Americas, regulatory clarity and an emphasis on clinical outcome data have driven demand for evidence-backed grafts and streamlined distribution channels, while purchaser consolidation within healthcare systems has increased the importance of value dossiers and contract flexibility. In Europe, Middle East & Africa, diverse regulatory regimes and heterogeneous payer landscapes emphasize localized regulatory strategy and targeted clinical education programs, and manufacturers must balance centralized CE and regional approvals with country-specific reimbursement practices. In Asia-Pacific, robust manufacturing bases and growing professional training initiatives are fostering rapid adoption of novel materials, yet local regulatory nuances and varying clinical protocols require tailored market entry approaches.

Across regions, logistical considerations such as cold chain requirements, import controls for biologics, and customs processing influence product selection and inventory approaches. Moreover, clinician training ecosystems differ by region, affecting how readily new grafting techniques and materials gain traction. Therefore, regional market strategies should align product development with local regulatory pathways, invest in clinician education that reflects regional surgical practices, and design supply chain solutions that address region-specific logistical and compliance challenges. This geographic perspective underscores the need for adaptable commercial models that respond to distinct regional drivers while leveraging global clinical evidence where applicable.

Competitive and corporate intelligence synthesizing product portfolios, R&D priorities, partnership models, and commercialization strategies among leading players

Competitive dynamics in the dental bone grafts and substitutes arena center on portfolio breadth, depth of clinical evidence, collaboration capacity, and supply chain reliability. Leading organizations differentiate through investments in product modularity, enabling clinicians to tailor graft selection to specific procedural demands while simplifying inventory management. In addition, firms that couple material innovation with robust clinical registries and surgeon-led trials demonstrate an ability to reduce adoption friction and translate technical advantages into clinician preference. Partnerships with academic centers and cross-border distribution alliances further strengthen market positioning by accelerating evidence generation and expanding access to new markets.

Strategic players are also leveraging manufacturing scale and quality systems to improve cost predictability and regulatory compliance, which in turn reassures institutional purchasers and high-volume clinical practices. Furthermore, companies that provide integrated educational support, digital planning tools, and outcome-tracking services increase their perceived value and foster longer-term clinician relationships. As competition intensifies, the ability to craft differentiated value propositions-rooted in clinical outcomes, supply reliability, and service offerings-will determine which players capture sustained traction in procedure-intensive environments.

Actionable recommendations for industry leaders to optimize R&D, supply resilience, reimbursement engagement, and clinician adoption strategies

Industry leaders should prioritize a pragmatic combination of scientific rigor, operational resilience, and commercial focus to accelerate sustainable adoption. First, invest in targeted clinical evidence generation that addresses procedure-specific endpoints and long-term integration outcomes, thereby enabling clinicians and payers to make informed comparisons among alternatives. Second, diversify supply chains and consider regional manufacturing or strategic partnerships to reduce exposure to tariff-driven disruptions and to shorten replenishment lead times for critical components. Third, align product development with clinician workflows by emphasizing handling properties, packaging convenience, and compatibility with digital surgical planning platforms to reduce intraoperative friction.

Furthermore, engage early and proactively with reimbursement stakeholders and professional societies to facilitate coding clarity and inclusion in clinical guidelines, while providing practical clinician education programs to shorten the learning curve for novel materials. Finally, adopt flexible commercial models that include outcome-based contracting, bundled procedural pricing, or tiered licensing for adjunct services to meet the needs of ambulatory surgical centers, dental clinics, and hospitals. By executing on these priorities, organizations can strengthen their competitive position while delivering measurable benefits to clinicians and patients.

Research methodology detailing data sources, stakeholder interviews, validation techniques, and analytical frameworks employed to ensure robust insights

This research integrates qualitative and quantitative approaches to ensure robust, reproducible insights grounded in primary stakeholder inputs and validated secondary evidence. Primary data sources include interviews with practicing oral surgeons, procurement leaders, and clinical researchers, supplemented by a review of regulatory filings, product labeling, and peer-reviewed clinical literature. Secondary validation involved cross-referencing public regulatory documents and procedure coding guidance to ensure interpretations align with current practice and compliance requirements. Triangulation across these inputs minimizes bias and strengthens the reliability of conclusions drawn about clinical utility, product characteristics, and operational considerations.

Analytical techniques include comparative product profiling, supply chain risk assessment, and scenario analysis for policy perturbations such as tariff changes. Quality assurance procedures encompassed source verification, methodological transparency, and iterative expert review to refine hypotheses and ensure that recommendations reflect real-world constraints. Where appropriate, findings were stress-tested against clinician feedback and procurement case studies to validate applicability across ambulatory centers, private dental practices, and hospital settings. This methodological combination supports actionable insights while maintaining fidelity to clinical realities and regulatory contexts.

Conclusion synthesizing strategic takeaways on clinical trends, technology convergence, and operational priorities for stakeholders across the value chain

The evolving dental bone grafts and substitutes landscape presents both opportunities and constraints that demand strategic clarity from participants across the value chain. Advances in materials and surgical techniques create the potential for improved patient outcomes and streamlined procedures, yet adoption will hinge on credible evidence, predictable supply, and alignment with reimbursement frameworks. Operational imperatives such as supply chain diversification and clinician-focused product design will determine which innovations translate into routine clinical practice, while regional regulatory and logistical factors will necessitate adaptable go-to-market approaches.

In closing, stakeholders who integrate rigorous clinical research, resilient manufacturing strategies, and targeted clinician engagement will be best positioned to convert technical innovation into sustained clinical uptake. Moving forward, the most successful organizations will balance the pursuit of differentiated graft technologies with pragmatic investments in evidence generation, regulatory navigation, and commercial models that reflect the priorities of ambulatory surgical centers, dental clinics, and hospitals. These strategic priorities provide a clear pathway for organizations seeking to make an enduring impact in regenerative dental care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dental Bone Grafts & Substitutes Market, by Product Type

  • 8.1. Allografts
    • 8.1.1. Demineralized Freeze Dried Bone Allograft (DFDBA)
    • 8.1.2. Freeze Dried Bone Allograft (FDBA)
  • 8.2. Autografts
  • 8.3. Composite Grafts
    • 8.3.1. Ceramic Composites
    • 8.3.2. Organic Composites
  • 8.4. Synthetic Grafts
    • 8.4.1. Bioactive Glass
    • 8.4.2. Ceramics
    • 8.4.3. Polymers
  • 8.5. Xenografts
    • 8.5.1. Bovine
    • 8.5.2. Porcine

9. Dental Bone Grafts & Substitutes Market, by Material

  • 9.1. Bioactive Glass
  • 9.2. Calcium Sulfate
  • 9.3. Composite Materials
  • 9.4. Hydroxyapatite
  • 9.5. Tricalcium Phosphate

10. Dental Bone Grafts & Substitutes Market, by Application

  • 10.1. Implant Site Preparation
  • 10.2. Ridge Augmentation
  • 10.3. Sinus Lift
  • 10.4. Socket Preservation

11. Dental Bone Grafts & Substitutes Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Dental Clinics
  • 11.3. Hospitals

12. Dental Bone Grafts & Substitutes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Dental Bone Grafts & Substitutes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Dental Bone Grafts & Substitutes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Dental Bone Grafts & Substitutes Market

16. China Dental Bone Grafts & Substitutes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. BioHorizons, Inc.
  • 17.6. botiss biomaterials GmbH
  • 17.7. Collagen Matrix, Inc.
  • 17.8. curasan AG
  • 17.9. Dentium Co., Ltd.
  • 17.10. Dentsply Sirona Inc.
  • 17.11. Envista Holdings Corporation
  • 17.12. Geistlich Pharma AG
  • 17.13. Institut Straumann AG
  • 17.14. Johnson & Johnson
  • 17.15. Kuros Biosciences AG
  • 17.16. LifeNet Health, Inc.
  • 17.17. Medtronic plc
  • 17.18. NovaBone Products LLC
  • 17.19. OsteoBiol
  • 17.20. Osteogenics Biomedical, Inc.
  • 17.21. Purgo Biologics Co., Ltd.
  • 17.22. RTI Surgical, Inc.
  • 17.23. Stryker Corporation
  • 17.24. ZimVie Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DEMINERALIZED FREEZE DRIED BONE ALLOGRAFT (DFDBA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DEMINERALIZED FREEZE DRIED BONE ALLOGRAFT (DFDBA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DEMINERALIZED FREEZE DRIED BONE ALLOGRAFT (DFDBA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY FREEZE DRIED BONE ALLOGRAFT (FDBA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY FREEZE DRIED BONE ALLOGRAFT (FDBA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY FREEZE DRIED BONE ALLOGRAFT (FDBA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ORGANIC COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ORGANIC COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ORGANIC COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BIOACTIVE GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BIOACTIVE GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BIOACTIVE GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BIOACTIVE GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BIOACTIVE GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BIOACTIVE GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CALCIUM SULFATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CALCIUM SULFATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY IMPLANT SITE PREPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY IMPLANT SITE PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY IMPLANT SITE PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY RIDGE AUGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY RIDGE AUGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY RIDGE AUGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SINUS LIFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SINUS LIFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SINUS LIFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SOCKET PRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SOCKET PRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SOCKET PRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 174. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 175. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 176. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 177. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. GCC DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 201. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 202. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 203. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 204. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. G7 DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 210. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 211. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 212. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 213. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NATO DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COMPOSITE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA DENTAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)